[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Blood Typing, Grouping and Infectious Disease NAT Screening Market 2021: Sales and Market Shares of Major Suppliers by Test and Country

September 2017 | 117 pages | ID: BEB6990353AEN
Venture Planning Group

US$ 7,450.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This unique report from LeadingMarketResearch provides sales and market share estimates for major suppliers of blood typing, grouping and infectious disease screening products by test and country.

The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.

Competitive Assessments
  • Abbott
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biokit
  • BioMerieux
  • Bio-Rad
  • CellMark Forensics/LabCorp
  • Diagast
  • DiaSorin
  • Fujirebio
  • Grifols
  • Hologic/Gen-Probe
  • Immucor
  • Ortho-Clinical Diagnostic
  • Proteome Sciences
  • Quest
  • Quidel
  • Roche
  • Siemens
  • Tecan
  • Thermo Fisher
Contains 117 pages and 38 tables

COMPETITIVE ASSESSMENTS

Abbott
Beckman Coulter/Danaher
Becton Dickinson
Biokit
BioMerieux
Bio-Rad
CellMarket Forensics/LabCorp
Diagast
DiaSorin
Fujirebio
Grifols
Hologic/Gen-Probe
Immucor
Ortho-Clinical Diagnostic
Proteome Sciences
Quest
Quidel
Roche
Siemens
Tecan
Thermo Fisher


More Publications